Skip to main content
Caplight Logo









Olgram

Olgram

Private
FranceHealthcare & Life Scienceshttps://www.olgram.com/

Last Round

Grant

Jun 7, 2024

Total Funding Raised

$6.79M

Company Overview

Olgram is a biotechnology company that develops marine-derived molecules to treat immune deficiencies and chronic bacterial infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyimmunomodulatory therapydrug discoveryantimicrobial resistanceAMRpreclinical researchinfectious diseaseantibiotic resistancedrug developmentbiotech startuptherapeutic candidatecontract R&Ddrug pipelinepharma partnershipnew drug modalities

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Olgram Comparables

Compare Olgram with similar companies based on industry and business-model similarity.

Olgram comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ingineeon GmbH
78%
Affirma Biotech
78%
MetrioPharm AG
75%

Olgram Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 7, 2024
SeedMar 31, 2021
Pre SeedMar 1, 2020

Key People

Founding team and executive leadership

Pierre Rocheteau

Founder and CEO

Founding Team

Olgram Investors

Notable investors and investment history

Olgram investors
InvestorRounds
Region BretagneSeed
BpifranceGrant, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 7, 2024

    $2.8M grant received from Bpifrance.

  • Mar 31, 2021

    $1.76M raised from Bpifrance and Region Bretagne.

Olgram Filings

Explore SEC and related filing metadata, where available.

Olgram filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Olgram's valuation, stock price, and market status.

Is Olgram a public or private company?

Olgram is a private company.

What is the current stock price of Olgram?

Olgram is a private company with no public stock price. Caplight tracks Olgram's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Olgram worth (valuation)?

Valuation information for Olgram is not publicly available.

Can I buy Olgram stock?

Olgram shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Olgram's last funding round?

Olgram's most recent funding round was Grant on June 7, 2024.

Who are the main investors in Olgram?

Key investors in Olgram include Region Bretagne, Bpifrance.

Will Olgram IPO soon?

No public IPO plans have been announced for Olgram.

How can I track Olgram secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Olgram's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFrance
Employee Range6
Year Founded2019
Last FundingJun 7, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?